SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-171212
Filing Date
2019-06-12
Accepted
2019-06-12 16:02:00
Documents
4
Period of Report
2019-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d742586d8k.htm 8-K 21366
2 EX-10.1 d742586dex101.htm EX-10.1 63177
3 EX-99.1 d742586dex991.htm EX-99.1 6013
4 GRAPHIC g742586g14v85.jpg GRAPHIC 3278
  Complete submission text file 0001193125-19-171212.txt   96644
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 19893621
SIC: 2834 Pharmaceutical Preparations